Life Sciences Translation Services Market Size to Reach USD 2,700.0 Million in 2032
The Life Sciences Translation Services Market size was USD 1,338.6 Million in 2024 and is expected to register a revenue CAGR of 9.1% during the forecast period
March 28, 2025 – Growth in medical tourism and cross-border healthcare is a key driver driving Life Sciences Translation Services market revenue growth. Technological innovation is a major driving element behind the expansion of medical tourism. Emerging medical tourism trends, like telemedicine, robotic surgery, and AI-driven diagnostics, are transforming healthcare delivery, making high-quality care more accessible and efficient for overseas patients. Many medical tourists combine their healthcare demands with wellness therapies. Countries recognized for their holistic approaches to health, such as India, Thailand, and Costa Rica, are seeing an increase in medical tourism as individuals seek spa therapies, yoga retreats, and traditional medicine in addition to conventional medical treatments.
Technological improvements are also contributing significantly to the market’s expansion. Innovations in interpretation tools, together with an increase in demand for interpreting services, are satisfying the needs of life sciences enterprises seeking culturally appropriate medical marketing content. AI-driven translation, such as Neural Machine Translation (NMT), provides an efficient alternative. NMT systems use powerful algorithms to translate text fast and effectively, handling enormous amounts of data while adapting to pharmaceutical-specific terminologies.
Data security and confidentiality concerns are primary restraining factors limiting the growth of the market. Pharma and healthcare companies use patient data to provide individualized therapies and efficient care, but the industry’s digitization has raised new privacy and cybersecurity issues. Consumer health data, including insurance or prescription information, R&D intellectual property, and preclinical and clinical trial data, are especially vulnerable to cyber-security assaults. According to Cybersecurity Ventures, global cybercrime expenditures will total USD 10.5 trillion per year by 2025. Current geopolitical uncertainties, growing digitalization, and a scarcity of competent labor are expected to exacerbate the situation.
Key Highlights:
- Medical writing & editing segment is expected to have the fastest growth rate in 2024. The rapid development of machine translation (MT) technology has sparked widespread interest in its applications in a variety of areas, including life sciences. Companies in the pharmaceutical, medical, and clinical research industries are constantly looking for faster, more cost-effective ways to manage multilingual documentation. Researchers can benefit from MT by translating search results and abstracts from foreign languages, giving them instant access to research publications in many languages. This preliminary phase can aid in comprehending the basic idea of a document before deciding if a complete, detailed translation is required.
- Pharmaceutical & biotechnology companies segment is expected to account for the highest revenue share over the forecast period. The increasing prevalence of diseases, combined with technology developments, has fueled innovation and new research in the pharmaceutical and medical industries. When pharmaceutical companies try to enter new markets, they need translation to comply with the regulations. Drug labels, patient information leaflets, and clinical trial documentation must be translated into several languages so that people around the world can comprehend them. Translation promotes tailored patient treatment, making people more aware of their health. In the long run, it leads to fewer people contracting dangerous diseases because they care about themselves.
- North America accounted for largest market revenue share in the life sciences translation services market in 2024. The United States produces such a wide range of pharmaceuticals that it has acquired global reputation. Companies such as Johnson & Johnson, Abbott, Pfizer, and others are increasing the bar for prescription medications with ground-breaking breakthroughs. Medical translation services assist patients fully comprehend their treatment procedures by providing translations in their original language, which increases consumer satisfaction.
- Some major companies in the market report include Vistatec, Lionbridge Technologies, LLC, Language Scientific Inc, Morningside, Inc, Seprotec, TransPerfect Life Sciences, Milestone Localization Private Limited, Propio Language Services, Stepes, Janus Worldwide, Argos Multilingual, Welocalize Life Sciences, ALM Translations Ltd, BURG Translations, and Crimson Interactive Inc.
- On February 2025, Interpreters Unlimited (IU), a renowned language services provider, has teamed with Diya Health, a visionary digital health SaaS startup, to change healthcare communication through the implementation of AI-powered interpretation and multimedia translation services. This revolutionary cooperation is poised to transform language access in healthcare systems across the United States by providing rapid, secure, and cost-effective solutions that improve patient care and provider efficiency.
Unlock the key to transforming your business strategy with our Life Sciences Translation Services market insights –
Here is a comprehensive detailed report
Click this link to request your free sample
Navistrat Analytics has segmented life sciences translation services market based on service type, content type, application, and end-use:
- Service Type Outlook (Revenue, USD Million; 2022-2032)
- Clinical/Document Translation
- Localization Services
- Interpretation Services
- Medical Writing & Editing
- Transcription
- Others
- Content Type Outlook (Revenue, USD Million; 2022-2032)
- Documents & Written Content
- Digital & Online Content
- Audio & Video Content
- Application Outlook (Revenue, USD Million; 2022-2032)
- Clinical Trials & Research
- Regulatory Compliance & Submissions
- Medical Devices & Healthcare Products
- Marketing & Commercialization
- Others
- End-Use Outlook (Revenue, USD Million; 2022-2032)
- Pharmaceutical & Biotechnology Companies
- Medical Device Manufacturers
- Contract Research Organizations (CROs)
- Regulatory Agencies & Health Authorities
- Hospitals & Healthcare Providers
- Others
- Regional Outlook (Revenue, USD Million; 2022-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux
- Nordic Countries
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Oceania
- ASEAN Countries
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Turkey
- Rest of MEA
- North America